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To identify a suitable source of human cardiac precursor cells (CPC) for 
replacement cell therapies, we established the conditions to isolate 
precursors from the human fetal heart. Ventricles were collected 
from donation following voluntary pregnancy termination at 12 
weeks of gestation. Non-myocyte cells were isolated, and expanded 
in vitro. CPC were identi ed using immunostaining for Nkx2.5, Flk1 
and Isl1, and by measuring the expression levels of these markers 
by real-time PCR. Proliferating cells demonstrated Nkx2.5 staining 
and no α-actinin expression. A signi cant fraction of Nkx2.5+ cells 
expressed Flk1. A few Nkx2.5+ cells were also Isl1+ whereas no Flk1+ 
cells expressed this marker. The capacity of expanded cells to produce 
differentiated cardiomyocytes, smooth muscle cells and endothelial 
cells was then tested by switching the culture to a differentiation 
serum-free medium. Differentiation into cardiomyocytes, smooth 
muscle and endothelial cells was evaluated by immunostaining for 
α-actinin, sm-MHC and CD31 respectively. In addition, expression of 
cardiac-speci c (Nkx2.5, α-MHC, β-MHC), smooth muscle-speci c 
(sm-MHC) and endothelial-speci c (CD31) genes was measured using 
real-time PCR. Evidence for cardiogenic differentiation in the culture 
is supported by the signi cant increase in α-actinin+ cells (1 % and 20 % 
under expansion and differentiation conditions respectively) as well 
as by the upregulation of cardiac marker expression. Differentiation 
into smooth muscle cell type was also dramatically stimulated (0 % 
and 4 % respectively). Accordingly, sm-MHC expression was 25-fold 
increased. In contrast, no differentiation into endothelial cells was 
detected under these conditions. The engraftment and differentiation 
capacity of GFP-labeled CPC were tested in vivo by transfer into 
the heart of SCID mice after myocardial infarction. Seven days 
thereafter, engrafted cells were readily detected and demonstrated 
cardiac-commitment as shown by Nkx2.5 staining. At this stage, no 
differentiation into cardiomyocytes could be observed.
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With an autologous origin, high proliferation capacity and 
potentialities to differentiate into matures endothelial cells (EC), 
endothelial progenitor cells (EPC) have raised huge interest and 
offer new opportunities in vascular engineering. Currents protocols 
for isolation and differentiation of EPC requires at least 1 month 
to observe an endothelium-like morphology and about 2 months 
for con uent EC monolayer. We report here a new method to 
differentiate and expand EPC on polyelectrolyte multilayer  lms 
(PEM) which promotes rapid differentiation of EPC into EC.
Rabbit EPC isolated from leukocytes fraction were cultivated on 
a PEM or on Fibronectin (Fn) coated glass surfaces and jugular 
vein EC (JVEC) were used as control. Phase-contrast microscopy 
observations allowed to follow differentiation and morphological 
changes of the cells after 4, 14, 21 and 60 days. The evolution of 
the phenotype during the progressive differentiation of EPC into 
mature EC was also checked by confocal microscopy, verifying the 
expression of CD34, CD31, vWF and LDL uptake. The grey level 
quanti cation was used for the quantitative analyses of CD31, vWF 
and Dil-Ac-LDL expression.
After 4 days, the cells appeared to be round shaped without 
noticeable differences between the Fn and the PEM coated surface. 
Moreover, confocal microscopy observations have showed different 
stage of EPC going from early (CD34+/-) to late EPC (CD31+/- 
and vWF+/-) on both surfaces. After 14 days on PEM, EPC formed 
already a con uent monolayer and exhibited an endothelium-like 
morphology similar to those found in JVEC whereas on Fn, the 
similar cellular morphology was observed after 60 days of culture. 
Confocal microscopy observations after 14 days have indicated the 
full disappearance of CD34 expression, speci c of haematopoietic 
phenotype whereas CD31, vWF and Dil-Ac-LDL, speci c markers of 
matures EC, are expressed on both surfaces, signature of cellular 
differentiation. The grey levels quanti cation for these markers 
indicates an expression signi catively higher only on PEM close to 
matures EC compare to Fn.
The present study describes an easy method for expansion and 
differentiation of EPC seeded on PEM and demonstrate that this 
strategy accelerate the differentiation into EC.
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Contexte — L’augmentation de la fréquence des pathologies 
cardiovasculaires ainsi que les limites des thérapies disponibles, 
conduiront, ces prochaines décennies, à des besoins importants en 
substituts vasculaires, surtout de faibles calibres.
Objectif — Ce travail consiste à élaborer de nouvelles matrices 
naturelles vasculaires, répondant aux qualités nécessaires au 
remplacement de vaisseaux endommagés.
Méthodes — Nous avons choisi de valoriser des artères ombilicales 
d’origine humaines cryoconservées (a n de se rapprocher des 
conditions des banques vasculaires) et désendothélialisées en les 
fonctionnalisant avec un  lm de polyélectrolytes. Ces  lms sont 
construits par dépôts alternés d’hydrochlorure de polyallylamine 
(polycation) et de poly (sodium-4-styrène sulfonate) (polyanion). 
Pour le développement d’une surface luminale non thrombogène 
deux approches ont été envisagées :
1) — Favoriser la formation d’un néo-endothélium vasculaire sur un 
 lm qui se termine par une couche positive
